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ABSTRACT  
Hsin Chen: Evaluation of a New Biomimetic Cement (GEMOSIL) for Use in Endodontic 
Therapy as Compared to the Widely-Used Mineral Trioxide Aggregate (MTA) 
(Under the direction of Ching-chang Ko)  
  
MTA has proven to be an effective material for endodontic therapy. However, due to its 
long setting time and dentinal/gingival staining, its use is limited.  The aim of this study was to 
see if the new biomimetic cement GEMOSIL has comparable properties to MTA, such that it can 
be used as an alternative to MTA.  Compressive and biaxial strength, discoloration, antimicrobial 
effects, cell viability and biocompatibility were analyzed in this study.  The compressive and 
biaxial strength reached 93 MPa and 59 MPa, respectively, after fully dried.  GEMOSIL
CHX
 
demonstrated antibiotic properties against S. mutans and E. faecalis. GEMOSIL had no 
cytotoxicity against human pulp cells and promoted significantly more cell proliferation 
(p<0.05).  GEMOSIL demonstrated less discoloration when placed in extracted teeth (p<0.05).  
GEMOSIL showed biocompatibility with living tissues. From these initial tests, GEMOSIL has 
demonstrated better properties compared to MTA, prompting GEMOSIL to be a viable 
alternative to MTA. 
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INTRODUCTION 
 
Mineral Trioxide Aggregate (ProRoot MTA; Dentsply Tulsa Dental, Tulsa, OK) is 
currently the most popular endodontic cement.  It was developed by Torabinajed et al in 1993 at 
Loma Linda University as a root-end filling and perforation material.  It consists of tricalcium 
oxide, silicate oxide, bismuth oxide, tricalcium silicate, and tricalcium aluminate (1).  It sets in 
the presence of moisture and renders a pH of 12.5 (2).  The gel solidifies to a hard solid structure 
in approximately three to four hours in the oral cavity (2).  Several studies of MTA have 
demonstrated that the cement possesses many of the properties sought for in a root-end filling 
material.  The sealing ability of MTA in root-end filling was found to be superior to amalgam, 
IRM, and Super-EBA (3).  An in vivo animal study on monkeys demonstrated that MTA caused 
no periapical inflammation and allowed new bone formation directly against the material when 
used as a root-end filling (4).  Due to its superiority in its biocompatibility and sealing ability, 
MTA is now also used as pulp capping material (5), and for repair of perforations (6). 
Although MTA has demonstrated excellent properties when compared with traditional 
root-end filling materials such as amalgam or IRM, the cost is expensive.  Research has also 
reported that MTA exhibits some poor handling properties.  Fridland et al. (7) found that MTA 
mixture becomes overly viscous and difficult to deliver even when mixed at the manufacturer’s 
recommended proportion of powder to liquid.  Lee (8) stated that MTA has a long setting time 
which can be easily washed out during procedures.  Torabinajed et al (9) also listed several 
drawbacks for MTA such as slow setting time and permanent dentinal discoloration.  Bortoluzzi 
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et al (10) has reported cases of marginal gingival discoloration when MTA was used for 
perforation repair.   
The shortcoming of MTA had led to the need for the development of an alternative 
endodontic cement.  
GEMOSIL, a new biomimetic cement, was developed for orthopedic applications by Ko 
et al at University of North Carolina (UNC patent: US 12/685,743 2010 and 61/560,777 2011).  
It consists of gelatinous hydroxyapatite nanocomposite, calcium silica, and calcium hydroxide.  
Preliminary studies showed GEMOSIL has a faster setting time, and its chemical composition 
has the potential for effective osteogenesis and some antimicrobial properties.   
In the 1
st
 manuscript, we focused on testing properties of GEMOSIL as an endodontic 
cement. Mechanical strength, discoloration, antimicrobial effects, cell viability and 
biocompatibility were tested. During the initial antimicrobial property testing, GEMOSIL 
formula only showed effective inhibition of S. Mutans but not of E. Faecalis; which is the most 
common organism cultured from persisted endodontic infections (11).  
From literature, chlorhexidine was initially used as a general disinfectant because of its 
broad antibacterial action (12).  It was later shown to inhibit dental caries and reduce the 
formation of dental plaque (13).  In vitro inhibition studies have shown chlorhexidine to be 
effective against species found in infected root canals such as Enterococcus faecalis (14) and 
Streptococcus mutans (15), and it consequently was introduced as an endodontic irrigant in the 
early 1960’s (13). Chlorhexidine is increasingly being incorporated into endodontic materials 
due to its ability to increase antimicrobial properties and improve prognosis.  
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The 2
nd
 manuscript (article in press) is a study to further investigate the effects of 
incorporating chlorhexidine into the original GEMOSIL formula to determine if the 
antimicrobial properties of GEMOSIL can be enhanced against common pathogens found in 
endodontic infections. 
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ABSTRACT 
Mineral trioxide aggregate (MTA) is an effective material for endodontic 
therapy.  However, due to its long setting time and dentinal/gingival discoloration, its use is 
limited.  The objective of this study was to test the hypothesis that a new biomimetic cement, 
GEMOSIL, has physical/biological properties comparable to MTA in endodontic therapy.   
Samples of GEMOSIL were used to measure compressive and biaxial flexure strength 
with an Instron machine.  GEMOSIL and MTA were placed in pulp chambers of extracted 
human teeth for discoloration testing.  GEMOSIL and MTA were spin coated to 35 mm culture 
dishes, which were then seeded with pulp cells for viability testing.  Zones of inhibition against 
S. Mutans and E. Faecalis were measured with both materials.  GEMOSIL and MTA were also 
placed as a root-end filling material in rat incisors to assess biocompatibility with living tissues. 
The compressive strength of GEMOSIL reached 28 MPa after 2 hours of immersion in 
PBS and 93 MPa after fully dried.  Flexure strength ultimately reached 59 MPa.  GEMOSIL 
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demonstrated less discoloration when placed in pulp chambers of extracted teeth than MTA 
(p<0.05).  GEMOSIL presented no cytotoxicity and promoted significantly more proliferation 
than MTA when in contact with pulp cells (p<0.05).  S. Mutans was susceptible to both 
GEMOSIL and MTA, but E. Faecalis was only susceptible to GEMOSIL
CHX
.  Both materials 
showed biocompatibility as a retro-grade filling material in rats (p>0.05).  In conclusion, 
GEMOSIL has similar or better physical and biological properties as compared to MTA; thus 
GEMOSIL has potential to be a viable endodontic cement.  
 
INTRODUCTION 
 
There are 15 million endodontic therapies done each year in the United States.  Although 
this procedure has a high success rate, amidst ideal circumstances there can still be failures.  
When there is persistent periapical infection, conventional root canal therapy fails, and non-
surgical root canal re-treatment is not feasible, periradicular surgery (commonly known as 
apicoectomy) is often the preferred approach.  This procedure routinely consists of root-end 
exposure of the involved apex, resection of the apical 3mm of the root, a retro-filling preparation 
and the placement of a root-end filling material.  Various materials have been used as the root-
end filling material, such as amalgam, Intermediate Restorative Material (IRM), Super-EBA, 
glass ionomers and composite resins (1).  An ideal root-end filling material should prevent 
leakage of bacteria into the periapical tissue, it should be non-toxic, non-carcinogenic, 
biocompatible, insoluble, and have no shrinkage on setting (2).  Previous root-end filling 
materials have had a few drawbacks, such as corrosion in amalgam and higher concentration of 
eugenol in IRM and Super-EBA, which causes irritations in vital tissues. These drawbacks led to 
the development of Mineral Trioxide Aggregate (MTA). 
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Mineral Trioxide Aggregate (ProRoot MTA; Dentsply Tulsa Dental, Tulsa, OK) is 
currently the most popular endodontic cement.  It was developed by Torabinajed et al in 1993 at 
Loma Linda University as a root-end filling and perforation material.  It consists of tricalcium 
oxide, silicate oxide, bismuth oxide, tricalcium silicate, and tricalcium aluminate (3).  It sets in 
the presence of moisture and renders a pH of 12.5 (4).  The gel solidifies to a hard solid structure 
in approximately three to four hours in the oral cavity (4).  Several studies of MTA have 
demonstrated that the cement possesses many of the properties sought for in a root-end filling 
material.  The sealing ability of MTA in root-end filling was found to be superior to amalgam, 
IRM, and Super-EBA (5).  An in vivo animal study with monkeys has shown that when MTA 
was used for root-end filling, there was no periapical inflammation and new bone formed 
directly against the material (6).  Due to its superiority in its biocompatibility and sealing ability, 
MTA is now also used as pulp-capping material (7), and for repair of perforations (8). 
Although MTA has demonstrated adequate physical properties, superior biocompatibility 
and sealing ability when compared with traditional root end filling materials such as amalgam or 
IRM, the cost is expensive.  Research has also reported that MTA exhibits some poor handling 
properties.  Fridland et al. (9) concluded that MTA was difficult to handle due to its low 
viscosity when mixed with the manufacturer’s recommended amount of liquid.  Lee (10) stated 
that MTA can be easily washed out during procedures due to its long setting time.  Torabinajed 
et al (11) also listed several drawbacks for MTA such as slow setting time and permanent 
dentinal discoloration.  Bortoluzzi et al (12) has reported cases of marginal gingival discoloration 
when MTA was used for perforation repair. 
The shortcoming of MTA had led to the development of ProRoot MTA White (Dentsply 
Tulsa Dental, Tulsa, OK, 1998) in which the iron component was removed to improve the color 
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stability; however, there was little to no improvement in tooth/gingival staining (13).  ProRoot 
MTA White continued to show slow setting time and poor mechanical strength in a moist 
environment, thus the need for the development of an alternative endodontic cement exists.  
Recently, a new biomimetic cement, GEMOSIL, was developed for orthopedic 
applications by Ko et al at University of North Carolina (UNC patent: US 12/685,743 2010 and 
61/560,777 2011).  It consists of gelatinous hydroxyapatite nanocomposite, calcium silica, and 
calcium hydroxide.  Preliminary studies showed GEMOSIL has a faster setting time, and its 
chemical composition has the potential for effective osteogenesis and antimicrobial properties.  
GEMOSIL has also not demonstrated discoloration.   
All preliminary evidence suggests that GEMOSIL can be a new addition to existing 
endodontic cements including ProRoot MTA and its derivatives.  The aim of this study was to 
compare the physical properties (compressive and biaxial flexure strength), discoloration 
properties, biological properties (pulp cell proliferation effect and antimicrobial effect) and 
biocompatibility between MTA and GEMOSIL for endodontic therapy. 
MATERIAL AND METHODS 
MATERIALS 
 
GEMOSIL 
100 milligrams of HAP-Gel powder, 200 milligrams of Ca(OH)2 powder, 300 microliters 
of enTMOS solution and 40 microliters of PBS were sequentially added and mixed to make 
GEMOSIL samples.   
MTA 
 
The MTA (grey formula, ProRoot MTA; Dentsply, Tulsa, OK) samples were prepared 
according to the manufacturer’s instructions (powder mixed with recommended amount of sterile 
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MTA water provided by the manufacturer). 
Compression Strength 
20 cylindrical GEMOSIL samples (4 mm diameter by 8 mm height) were prepared and 
either immediately placed in PBS for 2 hours or allowed to air dry for 48 hours.  Samples were 
compressed using an Instron 4411 (Instron Co., Norwood, MA) at a crosshead speed of 0.5 
mm/min to determine ultimate failure strength σult.  The stress-strain curve was recorded via the 
Testworks 4 software (MTS, Eden Prarie, MN) and the highest stress at failure was identified as 
σult.  
Biaxial Flexure Strength 
The general testing procedure for biaxial flexure strength was performed according to 
Ban and Anusavice (J Dent Res 69(12):1791-1799, 1990).  10 GEMOSIL disc samples (diameter 
12mm by thickness 1mm) were prepared in Teflon molds.  The upper and lower surfaces were 
polished in order to obtain parallel surfaces with no apparent defects.  After measuring the 
sample diameter (d) and thickness (t), the disk was supported on three stainless steel balls (3mm 
in diameter), which were equally spaced along a 5mm radius (rs).  Prior to testing, a stainless 
steel piston (radius = rp=1.5mm) was aligned concentrically with the three balls.  A crosshead 
speed of 0.5mm/min was used, and the maximum force at failure (P) was determined.  A 
Poisson’s ratio (ν) of 0.3 was used for all materials unless the exact value was known.  The 
flexure stress at failure (σ in MPa) was calculated using the following expressions: σ = AP/t2 and 
A = (3/4π) [2 (1+ν) ln(rs/ro) + (1-ν) (2 rs
2
-ro
2
) / 2 (d/2)
2
 + (1+ν)] where ro = (1.6 rp
2
 + t
2
)
1/2
 – 
0.675t.   
Discoloration 
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Ten extracted human single-rooted teeth per group were used to test dentinal 
discoloration of GEMOSIL and MTA.  The teeth were collected based on the following criteria: 
no caries or restorations present and no previous root canal treatments.  Teeth were air dried for 
24 hours then mounted with regisil material to standardize angulation, and pre-op photographs 
were made (both facial and lingual).  Each tooth was then accessed from the lingual surface, and 
all coronal pulp tissue (if any) was removed.  3mm of MTA and GEMOSIL were placed in the 
pulp chamber.  A cotton pellet soaked with chlorohexidine was placed on top of the material and 
IRM was used to restore access.  Samples were placed in PBS on a shaker for 48 hours.  Teeth 
were then allowed to air dry for 24 hours, then post-op photographs were made with the same 
regisil mount and color change was analyzed using the following described procedure. 
The quantification results of discoloration were derived from color differences (δ) by 
CIELAB method. Optical color measurement, CIELAB (the Commission Internationale de 
I'Eclairage) tristimulus values, is based on the principle of light transmission which is 
wavelength-dependent.  Given an externally applied illuminating light to the stain, the detectable 
color spectrum is used as a signal to differentiate and analyze the degree of discoloration.  The 
tooth colors of the digital images were converted to CIELAB tristimulus values for each image 
pixel.  The tristimulus values (L, a*, and b*) of three evenly distributed points from each tooth 
for both the pre- and post-op photos were measured using Photoshop software (Adobe System 
Inc., CA).  For each material group, the formula to calculate the discoloration was a color 
difference between the teeth before placement of the material and after placement of the 
material, δ = ((L-Lo)
2
+(a*-a*o)
 2
+(b*-b*o)
2
)
1/2
 where (L, a*, b*) and (Lo, a*o, b*o) were 
tristimulus values for teeth after placement of the material and teeth before placement of the 
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material, respectively.  The mean δ was compared among two groups at different durations using 
the student t-test.  
Pulp Cell Isolation 
Dental pulp cells were isolated from non-carious human third molars, which were 
extracted for clinical reasons.  Tooth surfaces were cleaned by submersion in Betadine for one 
minute and then cleaned with 70% ethanol.  Pulp tissue was removed with a broach (Lexicon 
Barded Broaches, Dentsply Tulsa Dental, Tulsa, OK) after accessing the tooth.  After the pulp 
tissue was removed, cells were isolated by enzyme digestion.  The pulp tissue was digested in a 
solution of collagenase type II (2 mg/ml).  The cell suspension was then filtered through a 40 
micrometer strainer, centrifuged, and pellets were suspended in Dulbecco’s modified Eagle’s 
medium (DMEM).  Single-cell suspensions were seeded onto a 100 mm culture plate in DMEM 
supplemented with 10% Fetal Bovine Serum, and 1% penicillin and streptomycin.  Culture plates 
were incubated in a humidified atmosphere of 95% air and 5% CO2 at 37°C and medium change 
was performed every three days.  Once a cell colony was formed, cells were trypsinized and 
redistributed in a new culture plate.  When cells reached confluence, they were harvested by 
trypsinization and sub-cultured.  Passage 3 was used for testing. 
Cell proliferation: BrdU Assay 
MTA and GEMOSIL were prepared and spin-coated onto petri dishes, and then allowed 
to air dry for 24 hours.  All petri dishes were sterilized under UV light overnight before the 
experiment. 
Each coated petri dish was then seeded with pulp cells.  Every day the medium was 
replenished with fresh growth medium.  At the end of cultivation (3 days), the dish was rinsed 
twice with PBS.  BrdU stain was applied.  Under the fluorescent light, nuclei were counted in 10 
13 
 
regions per dish for both groups and compared by the student t-test between the two groups. 
 
Antimicrobial Testing 
Incorporation of Chlorhexidine in Ca(OH)2 for GEMOSIL
CHX
 
CaCO3 (Alkaline analysis grade, Aldrich, USA) was calcinated to CaO in a furnace at 
1250
o
C for 3 hours.  Pure Ca(OH)2 was obtained through the hydration of the calcinated CaO.  
The hydration was carried out at 300
o
C using 3 times the stoichiometric amount of 0.12% 
chlorhexidine aqueous solution.  The final Ca(OH)2
CHX
 content was determined by measuring the 
dry weight [120
o
C for 3 h]. 
 
Disc Sample Preparation 
GEMOSIL was prepared and made into 6.2 mm x 0.85 mm discs.  A total of eight discs 
were made in a span of 15 minutes.  
MTA was prepared and made into 6.2mm x 0.85mm discs.  The MTA was given 30 
minutes to set due to its increased inclination to crack and fracture, which would render it 
impossible to use.   
For the control, paper discs were immersed in 0.12% chlorhexidine solution right before 
placing them on the agar plate. 
Microorganism 
The microorganisms investigated were Streptococcus mutans and Enterococcus 
faecalis.  Both organisms were a stock strain in the Oral Microbiology laboratory, University of 
North Carolina School of Dentistry.   
Zone of Inhibition 
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Bacterial sensitivity of each material was evaluated using the following assay – zone of 
inhibition of surface growth.  The materials were tested against Streptococcus mutans and 
Enterococcus faecalis using assays that measured the diffusible inhibition of bacterial growth on 
a blood-agar surface and estimated the antimicrobial activity.  All procedures were performed 
under aseptic conditions.   
Agar Diffusion Assay 
Inocula from frozen stock cultures were cultivated in Wilkins-Chalgren (W-C) broth 
(Oxoid Ltd. Basingstoke, Hampshire, England) at 37°C in ambient atmosphere, after being 
screened by Gram-staining to confirm purity.  Loopful inoculations of Streptococcus mutans 
and Enterococcus faecalis were transferred to 10 ml of appropriate broth and incubated at 37 °C 
under anaerobic conditions.  Bacterial suspensions were prepared to 0.5 MacFarland standard 
and diluted to a 1:10 concentration with W-C broth.  Two hundred ml of the 1:10 dilution were 
then taken and spread-plated using a “hockey stick” on a turntable to ensure confluent bacterial 
distribution on the plates.  
Test specimens were immediately placed on the freshly inoculated agar plates and 
aerobically incubated for 18-24 hours at 37°C.  Each plate contained 7 disc samples - two per 
material and a paper disc soaked with chlorhexidine at the center as the control.  This assay was 
performed in quadruplets.  After 18-24 hours, the diameters of the zone of inhibition of bacterial 
growth around the discs were measured using a caliper by two independent observers.  
Biocompatibility  
10 Sprague Dawley male rats were used in this study.  Cefazolin 0.06ml and 
Tetracycline-HCL (30mg/kg) were given before surgery.  General anesthesia was induced by 
intraperitoneal injection of a mixture of Ketamine (80mg/kg) and xylazine (10mg/kg).  Eye 
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ointment was applied.  The right and left sides of the mandible were shaved and cleaned with 
75% alcohol and β-dine.  Under aseptic conditions, an incision was made along the inferior 
mandible border and the mandible was exposed by dissecting the subcutaneous tissues and the 
masseter muscle.  Under irrigation, the buccal plate was perforated with a large round bur in a 
slow speed handpiece to expose the incisor apex (oval shape/open apex).  Once the apex was 
exposed and location of the canal was confirmed with the aid of an endodontic file, placement 
was attempted of 3mm of MTA or GEMOSIL at the apex as a root-end fill.  4.0 Vicryl suture 
was used to reposition the periostium and muscles and 4.0 Monocryl suture was used to close the 
incision.  Saline (10ml/kg) was administered subcutaneously after surgery.  All animals were 
monitored until they recovered from general anesthesia.  Cefazolin 0.06ml was administered 
intramuscularly once a day and Buprenorphine 0.1ml was administered subcutaneously twice a 
day for 3 days.  Soft diet was fed to the animals up to 7 days after the surgery.  All animals were 
euthanized with injection of an overdose of barbiturate on day 21 postoperatively.  Both left and 
right sides of the mandible were submitted for non-decalcified histological slides to determine 
inflammation levels in the PDL, pulp and periapical tissue adjacent to the material for both 
materials.  Chi-square test was used to compare the two groups. 
RESULTS 
Mechanical Property 
GEMOSIL’s compressive strength was 28 MPa after 2 hours setting in PBS and reached 
93 MPa after fully dried. Biaxial flexure strength was 59 MPa.  The results appear to be better to 
those of MTA reported in the literature (1, 14).  
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 GEMOSIL MTA 
Setting Time 5 min (15) 3-4 hours (1, 14) 
Compressive 
Strength 
28 MPa (2 hours) 
93 MPa (fully dried) 
40 MPa (24 hours) 
67.3 MPa (21 days)  
(1, 14) 
Biaxial Strength 59 MPa No Available Data 
Table 1 Comparison between mechanical properties of GEMOSIL and MTA 
 
Discoloration 
Figure 1 shows examples of pre-op and post-op photographs for the MTA group.  Figure 
2 shows examples of pre-op and post-op photographs for the GEMOSIL group.  Discoloration 
can be seen clearly on a few of the MTA samples.  The comparisons of the L, a*, and b* values 
are presented in Figure 3.  δ and SD values for each group are listed in Table 2.  There was a 
significant difference in color change between the MTA and GEMOSIL group (p<0.05). 
 
 
Figure 1 MTA (top) Initial, no discoloration (bottom) 3 days after, grey discoloration in cervical 
third 
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Figure 2 GEMOSIL (top) Initial, no discoloration (bottom) 3 days after, slight/no discoloration 
in cervical third  
 
 
Figure 3 The comparison of L, a* and b* values, pre-op and post-op 
 
Material δ SD 
MTA 5.0251 3.0980 
GEMOSIL 1.7004 0.7079 
Table 2 δ and SD for MTA and GEMOSIL groups 
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Cell Proliferation 
Figure 4 shows the nuclei counts for the three groups, including the control group.  
Figure 5 shows the BrdU staining of the nuclei for all three groups.  There was a significant 
difference in the nuclei counts between the groups (p<0.05).  The GEMOSIL group had 
significantly more nuclei, indicating more cell proliferation. 
 
Figure 4 Cell count (nuclei) under BrdU staining with 3 day culture 
 
Figure 5 BrdU stain (green) for nuclei under cell proliferation 
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Antimicrobial Testing 
Figures 6 and 7 show photographs of the zones of inhibition for S. mutans and E. faecalis, 
respectively.  The data for the zones of inhibitions are presented in Tables 3 and 4.  Figure 8 plots the 
mean values of the zones of inhibition for all materials.  A greater value implies a better antimicrobial 
effect.  In the control, growth of both microorganisms was inhibited by chlorohexidine.  MTA, 
GEMOSIL, and GEMOSIL
CHX
 are inhibitory to S. mutans.  In this case, the means of the zones of 
inhibition were 17.7±0.76 mm for MTA, 15.58±1.41 mm for GEMOSIL, 17.08±0.64 mm for 
GEMOSIL
CHX
, and 16.45±1.5mm for Chlorhexidine.  
For E. faecalis, the means of the zones of inhibition were 0±0.0 mm for MTA, 0±0.0 mm 
for GEMOSIL, 8.18±0.73 mm for GEMOSIL
CHX
and 9.85±0.47mm for Chlorhexidine.  The data 
showed no zones of inhibition with MTA and GEMOSIL, compared to GEMOSIL
CHX
 and 
chlorohexidine, which showed zones of inhibition.  The difference among the materials was 
statistically significant (p<0.01). 
 
 
Figure 6 Photograph of the zones of inhibition in Streptococcus mutans.  In the dish, the upper 
right: GEMOSIL
CHX
, lower right: GEMOSIL, left: MTA, and center: Chlorhexidine. 
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Figure 7 Photograph of the zones of inhibition in Enterococcus faecalis.  In the dish, the upper 
right: GEMOSIL
CHX
, lower right: GEMOSIL, left: MTA, and center: Chlorhexidine. 
 
 
Material Plate 1 Plate 2 Plate 3 Plate 4 
MTA 17.2±0.01 18.7±0.71 17.7±0.71 17.2±0.01 
GEMOSIL 14.2±1.41 16.7±0.71 16.7±0.71 14.7±0.71 
GEMOSIL
CHX
 17.2±0.02 16.7±0.71 17.2±0 17.2±1.41 
CHX 18.2±0.28 17.2±0.28 15.2±0.57 15.2±0.28 
Table 3 Zones of inhibitions (diameter/mm) in Streptococcus mutans 
Material Plate 1 Plate 2 Plate 3 Plate 4 
MTA 0 0 0 0 
GEMOSIL 0 0 0 0 
GEMOSIL
CHX
 7.9±0.42 9.2±0 7.9±0.42 7.7±0.71 
CHX 9.2±0.28 9.8±0.57 10.2±0.28 10.2±0.28 
Table 4 Zones of inhibitions (diameter/mm) in Enterococcus faecalis 
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Figure 8 Plot of the mean values of the zones of inhibition comparing the four groups, p<0.01  
Biocompatibility  
There were a total of 18 samples submitted for histology, 9 samples for MTA and 9 
samples for GEMOSIL. Half of the samples were horizontally sliced and the other half were 
vertically sliced at the apex. 
Inflammation of the PDL and the pulpal and periapical tissue adjacent to material was 
analyzed. Almost all samples have mild inflammation, but there was no significant difference 
between the two materials (p>0.05).  Both materials showed new bone formation adjacent to the 
materials (Figure 9 for MTA and Figure 10 for GEMOSIL). 
One GEMOSIL sample showed cartilage formation (Figure 11) and one MTA sample 
showed formation of apical abscess (Figure 12).  
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Figure 9 New bone formation adjacent to MTA 
 
 
Figure 10 New bone formation found in GEMOSIL material 
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Figure 11 Cartilage formation adjacent to GEMOSIL material 
 
Figure 12 Apical abscess formation adjacent to MTA retro fill 
DISCUSSION 
The mechanical property testing determined the initial setting time of GEMOSIL to be 5 
minutes (15) and the mixture can be hardened in an ambient or PBS solution.  The faster setting 
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property and its capability of setting in moist environments make GEMOSIL a good candidate 
for a retrograde filling material during apicoectomy procedures.  The compressive strength (28 
MPa after 2 hours setting in water and 93 MPa after fully dried) appears to be superior to that of 
MTA reported in the literature.  Additionally, the formulation of GEMOSIL that incorporated 
chlorhexidine did not lead to a decrease in compressive strength. 
In discoloration testing, the GEMOSIL group demonstrated less color change than the 
MTA group when placed in pulp chambers of extracted teeth (p<0.05), which implies that 
GEMOSIL may cause less discoloration when used for vital pulp therapy in the esthetic zone of 
human dentition.  3 days could be too short for the materials to penetrate through dentinal 
tubules.  A longer storage period is recommended for future studies in order to fully understand 
the impact of discoloration on the facial side of the tooth.  Further testing will be necessary to 
determine whether the addition of chlorhexidine to the formulation of GEMOSIL impacts 
discoloration. 
In the biological property testing, the GEMOSIL scaffold presented no cytotoxicity when 
assessed by a viability assay and a 3 day culture with human dental pulp cells.  Short term pulp 
cell cultures show significantly more cell growth in GEMOSIL coated dishes compared to those 
of MTA (p<0.05).  GEMOSIL’s non-toxicity means it could be effective at maintaining pulp 
vitality in vital pulp therapy.  Previous GEMOSIL studies have shown higher mineralization 
rates in human osteoblasts, which combined with GEMOSIL’s cell proliferation effect, indicate 
it could possibly stimulate dentinal bridge formation.  Future tests are indicated to determine the 
optimal concentration of chlorhexidine to be added to the formulation of GEMOSIL
CHX
 without 
adversely affecting cell proliferation. 
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In testing the antimicrobial effect, S. Mutans was found to be susceptible to all three 
materials- GEMOSIL, GEMOSIL
CHX
 and MTA.  E. Faecalis was only susceptible to 
GEMOSIL
CHX
 and resistant to GEMOSIL and MTA. GEMOSIL
CHX
 demonstrates antimicrobial 
properties that may be highly effective against persistent endodontic infections when used as a 
root-end filling material.  The difference in zone of inhibition needs further investigation in order 
to determine its clinical significance. 
Lastly, in biocompatibility testing, both GEMOSIL and MTA showed biocompatibility 
with periapical tissues when placed in vivo as a root-end filling in rat incisors.  There were no 
adverse allergic reactions or skin irritation noted in the rats.  Histologically, all samples showed 
new bone formation adjacent to both materials.  There was no difference in PDL, pulpal or 
periradicular inflammation levels between the two materials (p>0.05).  GEMOSIL’s 
biocompatibility with rat tissues indicates promise for biocompatibility with other living tissues, 
including those of humans.  Due to anatomical differences, there are limitations to the rat model. 
To further understand how the material affects humans, future studies could consider the usage 
of an animal species more closely related to humans. 
In conclusion, GEMOSIL demonstrates similar physical and biological properties 
compared to MTA.  Continued study is necessary; however, initial testing finds that GEMOSIL 
and GEMOSIL
CHX
 could potentially become a viable substitute for MTA in endodontic therapy. 
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ABSTRACT 
The recently developed GEMOSIL, a nanocomposite material composed of gelatinous 
hydroxyapatite (HAP-GEL) and animosaline by pozzolanic crosslinking, provides a potentially 
improved alternative to current endodontic cements. The mechanical performance of fully dried 
GEMOSIL approximated that of cortical bone. In its pre-set form, the moldable cement 
solidified in approximately 5 minutes when submerged in water, primarily due to the pozzolanic 
crosslinking. The purpose of this study was to test if adding chlorhexidine to Ca(OH)2 during the 
formation of this material could provide enhanced antimicrobial effects. Four zones of inhibition 
were formed using GEMOSIL, GEMOSIL
CHX
, Mineral Trioxide Aggregate (MTA; Tulsa 
Dentsply), and Chlorhexidine as a control. Each material was prepared into disc samples (6.2mm 
x 0.85mm; 8 per material). The Enterococcus faecalis and Streptococcus mutans strains were 
cultured at 37
o
C under anaerobic conditions. Bacterial suspensions were evenly distributed on a 
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blood-agar plate surface. The MTA/GEMOSIL/GEMOSIL
CHX
/Chlorhexidine discs were placed 
on the inoculated blood-agar plates which were immediately incubated at 37
o
C for 18-24 hours 
under aerobic conditions. Results showed that the Chlorhexidine and GEMOSIL
CHX 
provided a 
similar antimicrobial effect to Enterococcus faecalis, while GEMOSIL and MTA did not. All 
four materials showed similar effects to Streptococcus mutans. In combination with previous 
reports showing osteogenesis of GEMOSIL, the GEMOSIL
CHX 
may be applicable to both 
orthopedic and endodontic cements.  
 
INTRODUCTION 
The biomimetic cement, GEMOSIL, consisting of gelatinous hydroxyapatite 
nanocomposite, calcium silica, and calcium hydroxide particles, was developed for orthopedic 
applications by Ko and co-workers (1,2).  
The advantages of GEMOSIL include hardening in a moist environment, moderately 
strong compressive strength (94 MPa) after dehydration, and biocompatibility with osteoblasts.  
Upon investigation, its properties appear to match some demands of an ideal endodontic cement 
including 1) good mechanical strength, 2) short setting time in the presence of moisture, 3) 
injectability, 4) absence of dentinal discoloration, 5) bioactive dentinogenesis or osteogenesis, 6) 
antimicrobial activity and 7) sealability.  Currently, mineral trioxide aggregate (MTA) is widely 
used as endodontic cement; however, MTA shows tooth/marginal gingiva staining, slow setting 
time, and poor mechanical strength in a moist environment (3,4,5,6).  This has led to the 
development of several new derivatives of MTA (Dentsply Tulsa Dental, Tulsa, OK, 1998), 
although none have significantly improved upon these problems.  
Our previous studies have shown that the working time of GEMOSIL is approximately 1-
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3 minutes, and the compressive strength reaches 28 MPa after two hours of setting in water and 
94 MPa after fully dried.  GEMOSIL’s chemical composition has shown the potential for 
effective in vitro osteogenesis and in vivo bone formation (7,8).  All evidence suggests that 
GEMOSIL can be a new addition to existing endodontic cements including MTA and its 
derivatives.  One missing property of GEMOSIL is the antimicrobial effect against common 
microorganisms found in infected root canals.  
Chlorhexidine initially was used as a general disinfectant because of its broad 
antibacterial action (9). It was later shown to inhibit dental caries and reduce the formation of 
dental plaque (10).  In vitro inhibition studies have shown chlorhexidine to be effective against 
species found in infected root canals such as Enterococcus faecalis (11) and Streptococcus 
mutans (12), and because of this, it was introduced as an endodontic irrigant in the early 1960’s 
(10).  Chlorhexidine is increasingly being incorporated into endodontic materials due to its 
ability to increase antimicrobial properties and improve prognosis.  
In the present study, we demonstrated that chlorhexidine solution can be incorporated into the 
synthesis of calcium hydroxide, labeled as Ca(OH)2 creation of a chlorhexidine-impregnated 
GEMOSIL (GEMOSIL
CHX
). With this newly formed material, we hypothesized that it can 
improve the antimicrobial effect of GEMOSIL.  
Ultimately, the purpose of this in vitro study was to determine if the addition of 0.12% 
chlorhexidine would enhance the antimicrobial activity of GEMOSIL, and to compare the 
antimicrobial activity to the widely used material MTA. 
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MATERIALS AND METHODS 
Incorporation Of Chlorhexidine In Ca(OH)2 For GEMOSIL 
CaCO3 (Alkaline analysis grade, Aldrich, USA) was calcinated to CaO in a furnace at 
1250
o
C for 3 hours.  Pure Ca(OH)2 was obtained through the hydration of the calcinated CaO.  
The hydration was carried out at 300
o
C using 3 times the stoichiometric amount of 0.12% 
chlorhexidine aqueous solution.  The final Ca(OH)2
CHX
 content was determined by measuring the 
dry weight [120
o
C for 3 h]. 
Disc Sample Preparation 
For each GEMOSIL sample, 100 mg of hydroxyapatite-gelatin powder and 200 mg of 
Ca(OH)2 were ground and mixed with 300 ul of 95% enTMOS and 40 ul of PBS.  The mixture 
paste was then pressed into 6.2 mm x 0.85 mm disc samples.  A total of eight discs were made 
in about 15 minutes prior to testing.  
For each MTA sample, two 200 mg packages of grey ProRoot MTA (Tulsa, Dentsply) 
were mixed with sterile water into paste form.  The resultant mixture was made into 6.2mm x 
0.85mm disc samples.  The MTA was given 30 minutes to set due to its increased inclination to 
crack and fracture, which would render it impossible to use.   
For the control, paper discs were immersed in 0.12% chlorhexidine solution right before 
placing them on the agar plate. 
Microorganism 
Microorganisms investigated were Streptococcus mutans and Enterococcus faecalis.  
Both organisms were a stock strain in the Oral Microbiology laboratory, University of North 
Carolina School of Dentistry.  
Antimicrobial Assay 
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Bacterial sensitivity of each material was evaluated using the following assay – zone of 
inhibition of surface growth.  The materials were tested against Streptococcus mutans and 
Enterococcus faecalis using assays that measured the diffusible inhibition of bacterial growth on 
a blood-agar surface and estimated the antimicrobial activity.  All procedures were performed 
under aseptic conditions.   
Agar Diffusion Assay 
Inocula from frozen stock cultures was cultivated in Wilkins-Chalgren (W-C) broth 
(Oxoid Ltd. Basingstoke, Hampshire, England) at 37°C in ambient atmosphere, after being 
screened by Gram-staining to confirm purity.  Loopful inoculations of Streptococcus mutans 
and Enterococcus faecalis were transferred to 10 ml of appropriate broth and incubated at 37 
°C under anaerobic conditions.  Bacterial suspensions were prepared to 0.5 MacFarland 
standard and diluted to a 1:10 concentration with W-C broth.  Two hundred ml of the 1:10 
dilution were then taken and spread-plated using a “hockey stick” on a turntable to ensure 
confluent bacterial distribution on the plates.  
Test specimens were immediately placed on the freshly inoculated agar plates and 
aerobically incubated for 18-24 hours at 37°C.  Each plate contained 7 disc samples - two per 
material and a paper disc soaked with chlorhexidine at the center as the control.  This assay was 
performed in quadruplets.  After 18-24 hours, the diameters of the zone of inhibition of bacterial 
growth around the discs were measured using a caliper by two independent observers.  
The data for each material were subjected to one-way ANOVA to determine if significant 
differences in zones of inhibition occurred between different materials.  Confidence level was set 
at p<0.05. 
In-Vitro Cell Cytotoxicity Testing Through MTS  
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Since chlorhexidine has an antimicrobial effect, it may also affect normal cell growth.  
MC3T3E1 preosteoblasts were cultured to test in vitro cytotoxicity for the GEMOSIL
CHX
 coated 
on the 35 mm culture dishes.  The proliferation of the MC3T3-E1 cells on the coated dishes was 
conducted using MTS assay.  The MTS absorbance of each group was measured on day 1, 3, 5, 
7, and 9 respectively at 490 nm using a Plate reader (Biorad, Hercules, CA USA).  The control 
used GEMOSIL.  The higher the absorbance, the more cell growth. 
RESULTS AND DISCUSSION 
Figure 1 shows photographs of the zones of inhibition for all testing samples.  The data 
for the zones of inhibitions are presented in Table 1 and Table 2.  Figure 2 plots the mean values 
of the zones of inhibition for all materials.  A greater value implies a better antimicrobial effect.  
In control, growth of both microorganisms was inhibited by chlorohexidine.  MTA, GEMOSIL, 
and GEMOSIL
CHX
 are inhibitory to Streptococcus mutans. In this case, the means of the zones of 
inhibition were 17.70±0.76 mm for MTA, 15.58±1.41 mm for GEMOSIL, 17.08±0.64 mm for 
GEMOSIL
CHX
, and 16.45±1.50 mm for CHX. 
For Enterococcus faecalis, the means of the zones of inhibition were 0.00±0.00 mm for 
MTA, 0.00±0.00 mm for GEMOSIL, 8.18±0.73 mm for GEMOSIL
CHX
, and 9.85±0.47 mm for 
CHX. The data showed no zones of inhibition with MTA and GEMOSIL, compared to 
GEMOSIL
CHX
 and chlorohexidine, which showed zones of inhibition.  The difference among the 
materials was statistically significant (p<0.05). 
The size of the zone of inhibition of an antibacterial substance depends on a couple 
factors: the toxicity of the substance for the particular microorganism and the diffusibility of the 
substance in the test agar being used.  The diffusibility of the substance is based on whether it is 
hydrophilic or hydrophobic, molecular size and its rate of release from the insoluble matrix in 
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which it is bound. Therefore the size of the zone of inhibition may not be entirely due to its 
toxicity to the microorganism.  
It had been shown that MTA has antimicrobial and antifungal effect (13, 14).  Several 
investigation reports that MTA has limited antimicrobial effect against some microorganisms 
(facultative/strict anaerobes) (15).  Al-Hezaimi et al evaluated the antimicrobial effect against 
two different kinds of MTA and found that grey MTA demonstrated signiﬁcantly more 
antimicrobial effects than white MTA when present in low concentrations (16).  Also, when it 
was compared between Enterococcus faecalis and Streptococcus sanguis, Enterococcus faecalis 
requires significant higher MTA concentration for growth inhibition (16).  In our study MTA 
only demonstrated growth inhibition to Streptococcus mutans but not Enterococcus faecalis. 
 
  
Figure 1. Photographs of the zones of inhibition in Streptococcus mutans (left) and in 
Enterococcus faecalis (right).  In each dish, the upper right: GEMOSIL
CHX
, lower right: 
GEMOSIL, left: MTA, and center: chlorhexidine. 
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Table 1. Zones of inhibitions (diameter/mm) in Streptococcus mutans 
Material Plate 1 Plate 2 Plate 3 Plate 4 
MTA 17.20±0.01 18.70±0.71 17.70±0.71 17.2±0.01 
GEMOSIL 14.20±1.41 16.70±0.71 16.70±0.71 14.70±0.71 
GEMOSIL
CHX
 17.20±0.02 16.70±0.71 17.20±0.00 17.20±1.41 
CHX 18.20±0.28 17.20±0.28 15.20±0.57 15.20±0.28 
 
Table 2. Zones of inhibitions (diameter/mm) in Enterococcus faecalis 
Material Plate 1 Plate 2 Plate 3 Plate 4 
MTA 0 0 0 0 
GEMOSIL 0 0 0 0 
GEMOSIL
CHX
 7.90±0.42 9.20±0.00 7.90±0.42 7.70±0.71 
CHX 9.20±0.28 9.80±0.57 10.20±0.28 10.20±0.28 
 
 
 
In this present study, GEMOSIL demonstrated antimicrobial activity against 
Streptococcus mutans but failed to demonstrate antimicrobial activity against Enterococcus 
faecalis (Table 2).   This study also evaluated the effect of antimicrobial activity when 
chlorhexidine was added to the formulation of GEMOSIL (GEMOSIL
CHX)
. In the case of 
GEMOSIL
CHX
, the antimicrobial efficiency against Enterococcus faecalis increased 
significantly (p<0.05).  In comparison with MTA, which is the most widely used endodontic 
cement, GEMOSIL
CHX
 demonstrated significantly more antimicrobial effects against 
Enterococcus faecalis. Because Enterococcus faecalis is the most common microorganism 
cultured from persisted endodontic infections (17), the growth inhibition demonstrated by 
GEMOSIL
CHX
 suggests that this newly developed cement may lend itself to certain endodontic 
treatment modalities.  
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Figure 2. Plot of the mean values of the zones of inhibition comparing the four groups. The 
greater the value, the better the antimicrobial effect. S. Mutan and E.F. stand for Streptococcus 
mutans and Enterococcus faecalis, respectively. 
 
In vitro cytotoxicity testing showed GEMOSIL
CHX 
did affect normal cell growth (Figure 
3) which is proportional to the increased level of MTS absorbance. Two-way ANOVA showed 
that the difference was significant for both factors, Day and Material. At the beginning of the 
culture, the chlorhexidine increased cell growth approximately 25% but then decreased around 
25% after day 7.  
When testing the viability of pulp cells in the presence of the new cement, the 
preosteoblast culture showed that GEMOSIL
CHX
 increased cell growth 25% from day 1 to day 5 
but decreased cell growth 25% after the day 5. It was not clear by what mechanisms the material 
affects cell cycles and whether the cells in the preosteoblast cell culture underwent apoptosis in 
the presence of chlorhexdine.  Future investigations on dose effect and cellular mechanisms are 
necessary in order to determine the applicability of this new cement to endodontic treatment.  
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Figure 3. MTS absorbance for GEMOSIL and GEMOSIL
CHX
, measured on day 1, 3, 5, 7, 
and 9 respectively.   
 
CONCLUSION 
Chlorhexidine-impregnated GEMOSIL appears to provide superior mechanical strength, 
faster setting time, and greater antimicrobial properties than MTA and therefore, may offer a 
better future therapeutic alternative for endodontic cement. 
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